HOME >> BIOLOGY >> NEWS
LA BioMed Medical/Research Briefs, July/August 2004

  • LA BioMed Supports Stem Cell Initiative
  • Ethnic Breast Cancer?
  • A Periodic Table For Biology

    La BioMed Supports Stem Cell Initiative

    In coalition with major health and business groups throughout California, LA BioMed has indicated its support for the California Stem Cell Bond Issue Initiative that recently qualified for November's ballot. The initiative will allocate money from a $3 billion bond to fund promising, California-based stem cell research.

    The initiative will distribute an average of $295 million per year over a 10-year period to fund stem cell research at California's universities and other advanced medical research facilities. It will fund all aspects of stem cell therapy development from basic research through clinical trials to the actual delivery of therapies to patients.

    Kenneth P. Trevett, President and CEO of LA BioMed, recently issued the following statement about the initiative:

    The stem cell initiative is a necessary step in the pursuit of scientific research because federal funding for stem cell research has been limited. Unquestionably, stem cell therapy is potentially the most important medical advance since the discovery of antibiotics. This critically important statewide initiative closes the federal funding gap and sets a new state model for advancing scientific research. From an economic standpoint, California will benefit from patents and royalties that result from the research. Construction of research facilities and new research jobs will generate millions of dollars in new tax revenues for California. More importantly, if stem cell research results in a single cure that reduces healthcare costs by just one percent, it would pay for itself several times over during the following decade and save lives along the way.

    Mr. Trevett is available to speak the merits of the stem cell initiative. To contact him, telephone or e-mail the Communicatio
    '"/>



  • Contact: David Feuerherd
    df@issuesmanagement.com
    310-215-0234
    Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
    30-Jul-2004


    Page: 1 2 3

    Related biology news :

    1. BioMed Central to consult funders and librarians over Open Access payment model
    2. BioMed Central explodes Open Access myths
    3. The Scientist and BioMed Central come together to publish high-impact magazine
    4. BioMed Central is pleased to announce the publication of Sydney Brenners autobiography
    5. BioMed Central to deposit e-journals with the British Library
    6. BioMed Central to consider charging authors for paper submissions
    7. Get Research on the move with BioMed Central
    8. BioMed Central to launch at microbiology meeting
    9. BioMed Central to free scientists and clinical researchers from copyright restrictions

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:11/13/2018)... ... November 13, 2018 , ... Pharmafusion LLC ... a featured presenter at the upcoming CBI Gross-to-Net (GTN) Summit in Philadelphia on ... Friday, November 16, where conference attendees will have the opportunity to “test drive” ...
    (Date:11/13/2018)... ... November 12, 2018 , ... ... virtual events and webinars, will be hosting its 9th Annual Clinical Diagnostics ... technologies and treatments available, and updates in regulatory processes to ensure patient safety ...
    (Date:11/9/2018)... ... November 08, 2018 , ... Boekel ... Heating blocks, also known as dry bath incubators are used in laboratories worldwide ... , For the new heating blocks, Boekel Scientific used the same interface ...
    Breaking Biology News(10 mins):
    (Date:11/5/2018)... NASHVILLE, Tenn. (PRWEB) , ... November 05, 2018 ... ... Accredited radiology and telemedicine company backed by Siemens Healthineers and several healthcare VC ... blockchain based radiology solution and making a history by purchasing tokens and obtaining ...
    (Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has ... Activator Like (TAL) effector code technology for applications in advancing research in epigenetic ... in plants. Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting ...
    (Date:11/3/2018)... ... , ... Triangle Insights Group, a premier life sciences consulting firm, announced today ... in the United States, appearing on this year’s Inc. 5000 list. Since its ... growth over the previous three years. , Separately, Triangle Insights was also ranked ...
    (Date:10/31/2018)... ... October 30, 2018 , ... ... trial at the Campbell Clinic in Memphis, Tennessee. This study enrolled 125 ... standard of care for managing pain after total knee replacement surgery (TKA). , ...
    Breaking Biology Technology:
    Cached News: